Crossmark

Rho-kinase inhibitor Y-27632 and hypoxia synergistically enhance chondrocytic phenotype and modify S100 protein profiles in human chondrosarcoma cells

Crossref DOI link: https://doi.org/10.1038/s41598-017-03958-5

Published Online: 2017-06-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Piltti, Juha

Bygdell, Joakim https://orcid.org/0000-0002-9833-4628
Fernández-Echevarría, Cecilia

Marcellino, Daniel https://orcid.org/0000-0002-4618-7267
Lammi, Mikko J. https://orcid.org/0000-0002-6181-9904
License Information

Text and Data Mining valid from 2017-06-16

Version of Record valid from 2017-06-16
More Information

Article History

Received: 25 November 2016

Accepted: 9 May 2017

First Online: 16 June 2017

Competing Interests

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below